19 May 2020: Original Paper
Bacterial and Fungal Infections After Liver Transplantation: Microbial Epidemiology, Risk Factors for Infection and Death with Infection
Weili Zhang ABCDEF 1, Wentao Wang D 2, Mei Kang A 3*, Siying Wu B 3, Ya Liu B 3, Quanfeng Liao B 3, Yuling Xiao A 3, Ying Ma D 3, Yi Xie A 1
DOI: 10.12659/AOT.921591
Ann Transplant 2020; 25:e921591
Abstract
BACKGROUND: Infections, especially bacterial and fungal infections, are the leading cause of high mortality after liver transplantation (LT). This research investigated the pathogenic spectrum, antimicrobial susceptibility results, and risk factors of infection and death with infection to better control such infections.
MATERIAL AND METHODS: A retrospective cohort study was performed, and 433 liver transplant recipients between January 2010 and December 2016 were analyzed.
RESULTS: We found 290 isolates of bacteria and fungi in 170 infected liver transplant patients. Significant independent risk factors for bacterial and fungal infections were prolonged hospital stay (OR 1.034, 95% CI 1.013~1.056, p=0.002), mechanical ventilation (OR 3.806, 95% CI 1.567~9.248, p=0.003), and liver failure (OR 2.659, 95% CI 1.019~6.940, p=0.046). Furthermore, postoperative MELD scores (OR 1.120, 95% CI 1.020~1.230, p=0.017) and septic shock (OR 12.000, 95% CI 1.124~128.066, p=0.003) were independent risk factors for death with infection. CRAB infection is the main pathogenic bacteria of septic shock in LT patients.
CONCLUSIONS: We found that 39.3% of recipients had at least 1 bacterial or fungal infection after LT. Shortening the length of hospital stay and early withdrawal of mechanical ventilation will reduce the risk of infection after LT. Patients with liver failure should be more vigilant against postoperative infection. Once an infection occurs, immediate assessment of the postoperative MELD score, early diagnosis of septic shock, and active search for pathogenic evidence for precise treatment will help improve patient prognosis. Routine screening for CRAB colonization before surgery will facilitate empirical use of effective antibiotics.
Keywords: Bacterial Infections, Liver Transplantation, Risk Factors, adult, Anti-Bacterial Agents, Female, Humans, Length of Stay, Liver Diseases, Male, Middle Aged, Mycoses, Postoperative Complications, Respiration, Artificial, Retrospective Studies
Background
Liver transplantation (LT) is an effective treatment for end-stage liver diseases. With the improvement of surgical techniques, post-LT management of complications, and the use of new immunosuppressive regimens, recipient survival after LT has increased steadily, with a current 5-year survival rate of between 70% and 80% [1,2]. However, the use of immunosuppressants also increases the risk of infection, leading to high mortality. In Europe, 18% of post-LT deaths are caused by infection [2]. The majority of infections are caused by bacteria (70%), followed by virus (10%) and fungus (8%) [3,4].
With the use of antibiotics, hospital-acquired infections are rising recently, especially multi-drug-resistant bacteria such as carbapenem-resistant
Material and Methods
STUDY DESIGN AND RECIPIENTS:
We conducted a retrospective cohort study that included all adult (age ≥18 years) patients undergoing LT at West China Hospital, from January 2010 to December 2016. The patients without regular outpatient follow-up were excluded. For the included patients, if infection occurred, they were often admitted to the hospital for treatment. In total, 433 recipients (358 males and 75 females) were included. The mean age was 47 years (range, 18–79 years). The study group consisted of those recipients who developed at least 1 bacterial or fungal infection within 1 year after LT. Demographic, microbiological, and clinical characteristics were assessed. This study was approved by the hospital Ethics Committee and was performed in accordance with the Declaration of Helsinki [10].
DATA:
All patients were reviewed for the detection of bacterial and fungal infections after LT, including the sites and period of infection, culture outcomes, and antimicrobial susceptibility results. Potential risk factors for bacterial or fungal infection and death with infection were collected after LT, including demographic data (sex and age); reasons for LT; time of hospitalization after LT; laboratory index, including prothrombin time (PT) and international normalized ratio (INR); and serum bilirubin, serum creatinine, and albumin. Scores of model for end-stage liver disease (MELD) were calculated.
IMMUNOSUPPRESSIVE AND REJECTION THERAPY:
All LT patients received primary standard immunosuppressive therapy, including tacrolimus (FK506) or cyclosporine combined with mycophenolate mofetil (MMF) and low-dose prednisone. Methylprednisolone was started intraoperatively (10 mg/kg/dose) and continued with tapering for the first 3 months after LT. The target level of tacrolimus was 8–12 ng/ml in the first 3 months, 7–10 ng/ml in 3–6 months, 6–8 ng/ml in 6–12 months, and <5 ng/ml after the first year. For cyclosporine, the target levels of peak concentration were 900–1100 ng/ml in the first 3 months, 800–1000 ng/ml in 3–6 months, 600–800 ng/ml in 6–12 months, and <500 ng/ml after the first year. Prednisolone was administered at a dose of 10 mg and gradually decreased to zero in the first 3 months. The onset of acute rejection was diagnosed by the patient’s clinical manifestations, laboratory medical tests, and liver biopsy. Rejection was mainly treated with methylprednisolone (3 mg/kg/day for 5 days) and increasing FK506 blood concentrations.
DEFINITION AND MICROBIOLOGY:
Infections included bacterial and fungal infections. The definition of urinary tract infection (UTI) was: >105 CFU/ml plus at least one of the following clinical signs: a. fever; b. functional urinary symptoms; and c. sepsis of unknown origin. The definition of pneumonia was: isolated pathogen from sputum or bronchoalveolar lavage fluid (BALF) plus at least 3 of the following clinical signs: a. radiological signs; b. fever; c. white blood cell(WBC) count <4000 cells/mm3 or >12 000 cells/mm3; d. cough; e. purulent pulmonary: secretions or change in odor, consistency, color, or quantity; and f. dyspnea, tachypnea, apnea, or grunting. The definition of blood stream infection (BSI) was: isolated pathogen from 1 or more percutaneous blood cultures plus fever, chills, or hypotension. The definition of spontaneous bacterial peritonitis (SBP) was: ascitic fluid culture positivity (bacterascites) and/or an ascitic fluid polymorphonuclear leucocyte count greater than 250/mm3 (0.25×109/L). The definition of septic shock [11] was: at least 2 of the following clinical signs: a. body temperature >38.0°C or <36.0°C; heart rate >90 beats/min; c. tachypnea >20 breaths/min or hyperventilation with PaCO2 <32 mmHg; d. WBC count >12 000 cells/mm3; or <4000 cells/mm3. Death with infection was defined as all-cause death in the perioperative period in infected patients after LT.
The microorganisms were cultured and identified according to standard operating procedures of various samples, including sputum, blood, urine, ascites, and bile. Susceptibility tests of the strains to antibacterial agents were performed by standard methods, and the patterns were reviewed and classified according to the CLSI (Clinical and Laboratory Standards Institute) guidelines.
STATISTICAL ANALYSIS:
Statistical analysis was performed using SPSS software, version 20 (SPSS, Inc., Chicago, IL). Categorical variables are expressed as absolute numbers and their relative frequencies. Continuous variables are expressed as mean±standard deviation (SD) if normally distributed, or as the median and interquartile range (IQR) if non-normally distributed. Patients who developed at least 1 bacterial or fungal infection within after LT were compared with those without infection during this period. Categorical variables were compared using the Pearson chi-square test or Fisher’s exact test, as appropriate. Continuous variables were compared using the
Results
RECIPIENTS CHARACTERISTICS:
Among 433 LT recipients considered in the study period, 170 (39.3%) had at least 1 infection documented within a median of 20 days (IQR 9–73) after LT. The median age was 47 years old and males accounted for 82.7% (358/433) of the population. The majority of the patients underwent LT due to liver cancer (n=217), including hepatitis B-related liver cancer (n=140) and other liver cancer (n=77), due to the following: liver cirrhosis (n=149), including hepatitis B-related cirrhosis (n=75), hepatitis C-related cirrhosis (n = 6), alcoholic liver cirrhosis (n=14), cholestasis (n=13), primary biliary cirrhosis (n=5), autoimmune hepatitis (n = 3), re-transplantation (n=4), Wilson’s disease (n=3), citrin deficiency disease (n=3), schistosomiasis liver cirrhosis (n=1), mixed cirrhosis (n=2), and other liver cirrhosis (n=20). The remaining cases involved liver failure (n=67), including hepatitis B-related liver failure (n=48) and other liver failure (n=19) (Table 1).
PATHOGENIC SPECTRUM:
We detected 290 episodes of bacterial or fungal infection in our study. Gram-positive bacteria, gram-negative bacteria, and fungi accounted for 20.0% (58/290), 67.9% (197/290), and 12.1% (35/290) of pathogens, respectively. The most common gram-negative bacteria were Acinetobacter baumannii (26.6%), Klebsiella pneumonia (14.1%), Pseudomonas aeruginosa (7.9%), Escherichia coli (6.2%), and Stenotrophomonas maltophilia (3.1%). The most common gram-positive bacteria were Enterococcus faecium (13.1%), Staphylococcus aureus (2.0%), and coagulase-negative Staphylococcus (1.7%). The fungal infections were mainly Candida (10.3%), Aspergillus (1.0%), and Cryptococcus (0.3%) (Table 2).
In total, pneumonia (53.1%) and bloodstream infections (13.8%) were the most common infections. Pneumonia were mainly caused by
We also compared the pathogenic spectrum of different MELD score groups. When MELD scores were less than 15, the most common pathogens were Acinetobacter baumannii, Klebsiella pneumonia, Enterococcus faecium, and Candida. When MELD scores were between 15 and 30, the most common pathogens were Acinetobacter baumannii, Enterococcus faecium, Pseudomonas aeruginosa, and Klebsiella pneumonia. In the group with MELD scores over 30, 8 strains were isolated (Table 3).
ANTIMICROBIAL SUSCEPTIBILITY RESULTS:
As shown in Table 4, 67.6% Klebsiella pneumonia isolates and 77.8% Escherichia coli isolates produced ESBLs. For Klebsiella pneumonia, the antibiotic with less than 10% resistance rate was polymyxin B; antibiotics with resistance rates between 10% and 20% were amikacin, cefotetan, carbapenems, piperacillin/tazobactam, and tigecycline. For Escherichia coli, antibiotics with resistance rates less than 10% were amikacin, cefotetan, nitrofurantoin, and carbapenems. For Pseudomonas aeruginosa, the resistance rate of amikacin was less than 25%, and for Acinetobacter baumannii, only polymyxin B and tigecycline were less than 25% (Table 4).
RISK FACTORS FOR INFECTION:
A comparison of patients with and without infection is shown in Table 5. Age, female patients, hospital stay, liver failure, and postoperative MELD scores, blood loss during operation, transfusions of packed RBC, transfusion FFP, and mechanical ventilation, urinary catheterization, and arteriovenous catheterization were identified as risk factors of infection. In contrast, the prevalence of liver cancer in the infection group (36.5%) was lower than that in the non-infection group (58.9%) (Table 5).
Multivariate analysis revealed that independent risk factors for infection recipients were prolonged hospital stay (OR 1.034, 95% CI 1.013~1.056, p=0.002), liver failure (OR 2.659, 95% CI 1.019~6.940, p=0.046), and mechanical ventilation (OR 3.806, 95% CI 1.567~9.248, p=0.003) (Table 4).
RISK FACTORS FOR DEATH WITH INFECTION:
The 170 infected patients were divided into a death group (n=26) and a survival group (n=144) according to whether perioperative death occurred. When we compared the 2 groups, we found that female sex, postoperative MELD scores, septic shock, multi-site infection, blood loss during operation, transfusions of packed RBC, and prolonged mechanical ventilation were risk factors for death with infection (Table 6).
Multivariate analysis revealed postoperative MELD scores (OR1.120, 95% CI 1.020~1.230, p=0.017) and septic shock (OR 12.000, 95% CI 1.124~128.066, p=0.003) as independent risk factors for death with infection (Table 6).
SEPTIC SHOCK:
Table 7 lists the clinical data of 16 patients with septic shock in the death with infection group, including 10 males and 6 females, whose median of age was 48.5 years (IQR 45–57.5) and the median of MELD score was 19 (IQR 10–25). Carbapenem-resistant Acinetobacter baumannii (CRAB) was isolated in 13 cases (81.25%) and Enterococcus faecium was isolated in 5 cases (31.25%).
Discussion
Bacterial and fungal infections are among the leading causes of death after LT. The present study assessed the clinical characteristics of patients with LT and analyzed the data on pathogenic microorganisms and antibacterial treatments to provide theoretical evidence for the prevention and treatment of infection after LT and to reduce the mortality rate of LT patients. Our research found that pathogenic bacteria isolated from LT patients generally have high resistance to antibiotics. Especially in patients with septic shock, the proportion of CRAB was very high, but the empirical antibiotic treatment was often ineffective. Furthermore, the analysis of the clinical characteristics of patients found that liver failure, but not than MELD scores, could predict the risk of infection in LT patients. However, MELD scores and septic shock could predict the risk of death in the infected patients.
In this study, 39.3% of recipients developed at least 1 bacterial or fungal infection after LT, which was lower than in 2 Chinese studies in Zhejiang province (68.6% [12] and 51.8% [13]). These differences might be caused by the different definitions of “infection”. In this study, we placed more emphasis on the diagnosis of pathogenic microorganisms. The most common reason for liver transplantation is liver cancer, especially cancer related to hepatitis B. HBV-related liver diseases are still an enormous threat, responsible for 60.7% of all liver transplantation in our study. Most infection (60.0%) occurred in the first month after LT, which was consistent with other studies. In all the positive culture specimens,
The results of antimicrobial susceptibility tests showed that 77.8% of
Age, sex, MELD scores, severe hepatitis, mechanical ventilation, post-transplant hospital time, renal failure, portal vein thrombosis, and biliary complications were significantly associated with bacterial and fungal infection in multiple studies [8,12,13,17–21]. To investigate the possible risk factors for bacterial and fungal infections after LT, we compared the infection group (n=170) and non-infection group (n=263), and found that prolonged hospital stay, liver failure, and mechanical ventilation were independent risk factors for infection after LT. It seemed that hospital stay was a risk factor for infection after LT, but we should realize there is a reciprocal relationship between hospital stay and infection. One the one hand, prolonged hospitalization may increase the risk for nosocomial infections; one the other hand, the infection can also prolong the time of hospitalization. Preoperative diagnosis of liver failure, but not postoperative MELD scores, was an independent predictor of infection after LT, suggesting that for patients with liver failure, more attention should be paid to the use of antibiotics before surgery and the monitoring of symptoms and indicators of postoperative infection. In particular, as long as the patient can tolerate it, early removal of mechanical ventilation will reduce the possibility of infection for LT patients.
Postoperative MELD scores were a predictor for infected-related death. Research has shown that the preoperative MELD score cannot predict recipient survival [22]. Our research showed that high postoperative MELD scores indicated a higher risk of death for infected patients, so it is necessary for clinicians to immediately evaluate MELD scores after LT in order to better care and treat patients. Moreover, the severe acute infection-septic shock was an independent predictor, as in multiple studies [5,23,24]. Kyo Won Lee [25] reported that the implantation of ECMO (extracorporeal membrane oxygenation) might be considered in highly selected LT recipients with refractory septic shock. Since septic shock was closely related to the death of LT patients, early diagnosis of septic shock will benefit patients’ survival. Researchers believed that the Sepsis-3 standard was based on the latest understanding of the pathobiology, treatment, and epidemiology of sepsis, which was accept as a more specific and sensitive definition compared with the previous definitions of sepsis [26]. Furthermore, in the 16 patients of septic shock, up to 13 cases (81.25%) isolated Carbapenem-resistant A
Conclusions
We found that 39.3% of recipients had at least 1 bacterial or fungal infection after LT.
References
1. Dutkowski P, De Rougemont O, Müllhaupt B, Clavien PA, Current and future trends in liver transplantation in Europe: Gastroenterology, 2010; 138(3); 802-9.e1–4, pmid: 20096694
2. Adam R, Karam V, Delvart V, Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR): J Hepatol, 2012; 57(3); 675-88, pmid: 22609307
3. Vera A, Contreras F, Guevara F, Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundacion Santa Fe de Bogota, Colombia: Transpl Infect Dis, 2011; 13(6); 608-15, pmid: 21794041
4. Romero FA, Razonable RR, Infections in liver transplant recipients: World J Hepatol, 2011; 3(4); 83-92, pmid: 21603030
5. Song SH, Li XX, Wan QQ, Ye QF, Risk factors for mortality in liver transplant recipients with ESKAPE infection: Transplant Proc, 2014; 46(10); 3560-63, pmid: 25498089
6. Santoro-Lopes G, de Gouvea EF, Multidrug-resistant bacterial infections after liver transplantation: An ever-growing challenge: World J Gastroenterol, 2014; 20(20); 6201-10, pmid: 24876740
7. Pereira MR, Scully BF, Pouch SM: Liver Transpl, 2015; 21(12); 1511-19, pmid: 26136397
8. Mouloudi E, Massa E, Papadopoulos S: Transplant Proc, 2014; 46(9); 3216-18, pmid: 25420863
9. Lübbert C, Hau HM, Rodloff AClinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients: Z Gastroenterol, 2015; 53(11); 1276-87, pmid: 26562402 [in German]
10. World Medical Association Declaration of Helsinki, Recommendations guiding physicians in biomedical research involving human subjects: Cardiovasc Res, 1997; 35(1); 2-3, pmid: 9302340
11. Levy MM, Fink MP, Marshall JC, 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference: Crit Care Med, 2003; 31(4); 1250-56, pmid: 12682500
12. Zhang ML, Xu J, Zhang W, Microbial epidemiology and risk factors of infections in recipients after DCD liver transplantation: Int J Clin Pract, 2016; 70(Suppl 185); 17-21, pmid: 27198000
13. Tu Z, Xiang P, Xu X, DCD liver transplant infection: Experience from a single centre in China: Int J Clin Pract, 2016; 70(Suppl 185); 3-10
14. Kawecki D, Pacholczyk M, Lagiewska B, Bacterial and fungal infections in the early post-transplantation period after liver transplantation: Etiologic agents and their susceptibility: Transplant Proc, 2014; 46(8); 2777-81, pmid: 25380916
15. Barchiesi F, Montalti R, Castelli P: BMC Infect Dis, 2016; 16(1); 538, pmid: 27716164
16. Sganga G, Bianco G, Fiori B, Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: A series from 2005–2011: Transplant Proc, 2013; 45(7); 2718-21, pmid: 24034031
17. Mukhtar A, Abdelaal A, Hussein M, Infection complications and pattern of bacterial resistance in living-donor liver transplantation: A multicenter epidemiologic study in Egypt: Transplant Proc, 2014; 46(5); 1444-47, pmid: 24935311
18. Zhong L, Men TY, Li H, Multidrug-resistant gram-negative bacterial infections after liver transplantation – spectrum and risk factors: J Infect, 2012; 64(3); 299-310, pmid: 22198738
19. van Hoek B, de Rooij BJ, Verspaget HW, Risk factors for infection after liver transplantation: Best Pract Res Clin Gastroenterol, 2012; 26(1); 61-72, pmid: 22482526
20. Oweira H, Lahdou I, Daniel V, Early post-transplant neopterin associated with one year survival and bacteremia in liver transplant recipients: Hum Immunol, 2016; 77(1); 115-20, pmid: 26582003
21. Kaido T, Ogawa K, Fujimoto Y, Perioperative changes of procalcitonin levels in patients undergoing liver transplantation: Transpl Infect Dis, 2014; 16(5); 790-96, pmid: 25154523
22. Yadav SK, Saraf N, Saigal S, High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients: Clin Transplant, 2017; 31(8)
23. Wan Q, Ye Q, Su T, Zhou J, The epidemiology and distribution of pathogens and risk factors for mortality in liver transplant recipients with Gram negative bacteremia: Hepatogastroenterology, 2014; 61(134); 1730-33, pmid: 25436370
24. Su H, Ye Q, Wan Q, Zhou J: Ann Transplant, 2016; 21; 86-93, pmid: 26856368
25. Lee KW, Cho CW1, Lee N, Extracorporeal membrane oxygenation support for refractory septic shock in liver transplantation recipients: Ann Surg Treat Res, 2017; 93(3); 152-58, pmid: 28932731
26. Wang Y, Gu Y, Huang F, Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation: Mediators Inflamm, 2018; 2018 8703172
27. Freire MP, Pierrotti LC, Oshiro IC: Liver Transpl, 2016; 22(5); 615-26, pmid: 26684547
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






